相关实验视频
Updated: Jan 8, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.7K
成年肥胖的流行病学
J H Goedecke1, J Hellig2, M Conradie-Smit3
1Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
|December 11, 2025
概括
肥胖是一种慢性疾病,损害健康,增加死亡风险. 医疗保健系统和政策必须通过基于证据的策略和持续的国家监测,专注于管理成人肥胖症.
科学领域:
- 公共卫生 公共卫生
- 慢性疾病管理 慢性疾病管理
- 流行病学 流行病学
背景情况:
- 肥胖症被定义为异常或多余的身体脂肪积累 (脂肪) 损害健康.
- 肥胖与过早发病和死亡的风险增加有关.
- 对肥胖的有效管理策略对于公共卫生至关重要.
研究的目的:
- 建议医疗保健提供者认识到肥胖是一种慢性疾病,并对其进行治疗.
- 在卫生系统和政策层面倡导基于证据的策略,以管理成人肥胖.
- 强调持续纵向国家和区域肥胖监测的重要性.
主要方法:
- 这些建议是基于对证据的审查,标记为 (2b级,B级).
- 这些建议涉及对肥胖的认识和治疗.
- 这些建议涵盖卫生系统和政策策略,以及监测方法.
主要成果:
- 医疗保健提供者应该认识到肥胖是一种慢性疾病,并对其进行治疗.
- 应制定卫生系统和政策策略,以管理成人肥胖.
- 应定期进行纵向的全国和区域肥胖监测,包括测量数据.
结论:
- 肥胖需要医疗保健提供者的认可和治疗,作为一种慢性疾病.
- 系统和政策层面的综合管理策略对于成人肥胖至关重要.
- 持续监测对于监测和应对肥胖流行病至关重要.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K

